🧪 Cough Syrup Deaths in India: Understanding the Contamination Crisis and Regulatory Response
The deaths of at least 16 children in Madhya Pradesh due to contaminated cough syrup (Coldrif) have once again exposed alarming gaps in India’s drug regulatory framework. Lab tests found 48.6% Diethylene Glycol (DEG) — 480× the permissible limit — in the syrup, a toxic industrial chemical that can cause acute kidney failure.
This isn’t an isolated tragedy. India has witnessed multiple DEG-linked cough syrup deaths over the decades, including international incidents that damaged its pharma reputation.
The crisis highlights deep systemic issues: regulatory fragmentation, weak enforcement, outdated testing infrastructure, and unsafe manufacturing practices. Reforms are essential to ensure medicine meant to heal never harms.
👉 Read the full analysis here: https://www.visionias.in/blog/current-affairs/cough-syrup-deaths-in-india-understanding-the-contamination-crisis-and-regulatory-response
The deaths of at least 16 children in Madhya Pradesh due to contaminated cough syrup (Coldrif) have once again exposed alarming gaps in India’s drug regulatory framework. Lab tests found 48.6% Diethylene Glycol (DEG) — 480× the permissible limit — in the syrup, a toxic industrial chemical that can cause acute kidney failure.
This isn’t an isolated tragedy. India has witnessed multiple DEG-linked cough syrup deaths over the decades, including international incidents that damaged its pharma reputation.
The crisis highlights deep systemic issues: regulatory fragmentation, weak enforcement, outdated testing infrastructure, and unsafe manufacturing practices. Reforms are essential to ensure medicine meant to heal never harms.
👉 Read the full analysis here: https://www.visionias.in/blog/current-affairs/cough-syrup-deaths-in-india-understanding-the-contamination-crisis-and-regulatory-response
😨3❤1
tgoop.com/VisionIAS_UPSC/56752
Create:
Last Update:
Last Update:
🧪 Cough Syrup Deaths in India: Understanding the Contamination Crisis and Regulatory Response
The deaths of at least 16 children in Madhya Pradesh due to contaminated cough syrup (Coldrif) have once again exposed alarming gaps in India’s drug regulatory framework. Lab tests found 48.6% Diethylene Glycol (DEG) — 480× the permissible limit — in the syrup, a toxic industrial chemical that can cause acute kidney failure.
This isn’t an isolated tragedy. India has witnessed multiple DEG-linked cough syrup deaths over the decades, including international incidents that damaged its pharma reputation.
The crisis highlights deep systemic issues: regulatory fragmentation, weak enforcement, outdated testing infrastructure, and unsafe manufacturing practices. Reforms are essential to ensure medicine meant to heal never harms.
👉 Read the full analysis here: https://www.visionias.in/blog/current-affairs/cough-syrup-deaths-in-india-understanding-the-contamination-crisis-and-regulatory-response
The deaths of at least 16 children in Madhya Pradesh due to contaminated cough syrup (Coldrif) have once again exposed alarming gaps in India’s drug regulatory framework. Lab tests found 48.6% Diethylene Glycol (DEG) — 480× the permissible limit — in the syrup, a toxic industrial chemical that can cause acute kidney failure.
This isn’t an isolated tragedy. India has witnessed multiple DEG-linked cough syrup deaths over the decades, including international incidents that damaged its pharma reputation.
The crisis highlights deep systemic issues: regulatory fragmentation, weak enforcement, outdated testing infrastructure, and unsafe manufacturing practices. Reforms are essential to ensure medicine meant to heal never harms.
👉 Read the full analysis here: https://www.visionias.in/blog/current-affairs/cough-syrup-deaths-in-india-understanding-the-contamination-crisis-and-regulatory-response
BY Vision IAS (Official)
Share with your friend now:
tgoop.com/VisionIAS_UPSC/56752